CONJU PRINCESS BB- arbutin cream

Conju Princess BB by

Drug Labeling and Warnings

Conju Princess BB by is a Otc medication manufactured, distributed, or labeled by Conju Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Active ingredient: titanium dioxide, arbutin, adenosine

INACTIVE INGREDIENT

Inactive ingredient: water, titanium dioxide,cyclopentasiloxzne, ethylhexyl methoxycinnamate,propylene glycol, cyclohexasiloxane, butylene glycol dicaprylate/dicaprate, cetyl/peg/ppe-10/1 dimethicone, dimethicone,hexyl laurate, arbutin, tale, PEG-10 dimethicone, panax ginseng root extract, sorbitan, olivate, magnesium sulfate, sorbitan sesquioleate, disteardimonium hectorite,quaternium-19bentonite, chamomilla recutita (matricaria) flower extract, silica, triethyl citrate, allantoin, tocopheryl acetate, dipotassium clycyrrhizate, iron oxide (CI 77492), iron oxide (CI 77491), iron oxide (CI 77499), ultramarines (CI 77007), triethoxycaprylylsilane, propylparaben, methylparaben, phenoxyethanol, adenosine, mica, sodim hyaluronate

PURPOSE

helps prevent sunburn

KEEP OUT OF REACH OF CHILDREN

keep out of reach of the children

INDICATIONS & USAGE

After following the daily skin care routine, apply the Conju Princess BB Cream generously onface and sensitive area. Reapply it again every two hours if sensitive exposure is contrast and also be used as a make-up base

WARNINGS

Warning
For external use only
When using this product
■ Avoid eye area. If contact occurs, rinse eyes thoroughly　with water
■ If following abnormal symptoms occurs after use, stop use and ask doctor
   red specks, swelling, itching

DOSAGE & ADMINISTRATION

- for external use only

- apply frequently when needed

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

CONJU PRINCESS BB 
arbutin cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 59915-1001
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	10.15 mL  in 100 mL
ARBUTIN (UNII: C5INA23HXF) (ARBUTIN - UNII:C5INA23HXF)	ARBUTIN	2 mL  in 100 mL
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567)	ADENOSINE	0.04 mL  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
OCTINOXATE (UNII: 4Y5P7MUD51)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
DIMETHICONE (UNII: 92RU3N3Y1O)
HEXYL LAURATE (UNII: 4CG9F9W01Q)
TALC (UNII: 7SEV7J4R1U)
ASIAN GINSENG (UNII: CUQ3A77YXI)
SORBITAN OLIVATE (UNII: MDL271E3GR)
MAGNESIUM SULFATE, UNSPECIFIED (UNII: DE08037SAB)
SORBITAN SESQUIOLEATE (UNII: 0W8RRI5W5A)
HECTORITE (UNII: 08X4KI73EZ)
BENTONITE (UNII: A3N5ZCN45C)
CHAMOMILE (UNII: FGL3685T2X)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
ALLANTOIN (UNII: 344S277G0Z)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
LICORICE (UNII: 61ZBX54883)
FERRIC OXIDE RED (UNII: 1K09F3G675)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
OCTYLTRIETHOXYSILANE (UNII: LDC331P08E)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
METHYLPARABEN (UNII: A2I8C7HI9T)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
MICA (UNII: V8A1AW0880)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 59915-1001-1	30 mL in 1 TUBE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		01/24/2011

Labeler - Conju Inc (012345486)